Irox-250/500

Home / Products

SFPL is leading towards Healthier Tomorrow

Irox-250/500

(CEFUROXIME 250/500 mg. TABLETS)

For Resistant Pathogens

Cefuroxime

  • Active againt gmve, gm-ve & beta lactamase
  • Attains higher CSF Concentration
  • Ideal in meningitis
  • Higher penetration in tissues

Potassium Clavunate

  • Kills even ESBL
  • Extended spectrum Beta Lactamasel
  • Producing Pathogens
  • Excellent coverage against G+ve & G-ve
Introduction
  • Acute Bacterial Otitis Media
  • Acute Bacterial Exacerbations of Chronic Bronchitis
  • Urinary Tract Infections
  • Skin & Soft tissue Infections
  • Switch Over Therapy
  • Bacterimia
  • Meningitis

Our Products